Lei et al., (2018) demonstrated that lncRNA H19 is secreted through hnRNPA2B1‐mediated packaging into exosomes, promoting resistance to gefitinib (an EGFR‐tyrosine kinase inhibitor) in NSCLC cells. Here, H19 is linked to non-small cell lung carcinoma.